By Michael Erman Oct 7 (Reuters) – The pharmaceutical industry's top lobby group on Wednesday sued to invalidate the Trump administration's efforts to benchmark US drug prices to lower costs overseas
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Fed minutes show some officials want to prepare for market stress
By Michael S. Derby Oct 7 (Reuters) - Federal Reserve meeting minutes from last month’s…
Former Spurs defender Vega declares intention to run against Infantino
VIDEO SHOWS: ARCHIVE STILL PHOTOGRAPHS OF FORMER SWISS INTERNATIONAL DEFENDER RAMON VEGA / ARCHIVE MATERIAL…
Lightning hope to shake off power-play woes as Wild visit
The bad news for the Tampa Bay Lightning is the power play continues to struggle…
